Kathi Niffenegger
2022
In 2022, Kathi Niffenegger earned a total compensation of $542K as Chief Financial Officer at Edesa Biotech, a 48% decrease compared to previous year.
Compensation breakdown
| Bonus | $87,000 |
|---|---|
| Option Awards | $109,329 |
| Salary | $295,075 |
| Other | $50,546 |
| Total | $541,950 |
Niffenegger received $295.1K in salary, accounting for 54% of the total pay in 2022.
Niffenegger also received $87K in bonus, $109.3K in option awards and $50.5K in other compensation.
Rankings
In 2022, Kathi Niffenegger's compensation ranked 4,122nd out of 5,505 executives tracked by ExecPay. In other words, Niffenegger earned more than 25.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,122 out of 5,505 | 25th |
Division Manufacturing | 2,318 out of 2,984 | 22nd |
Major group Chemicals And Allied Products | 1,114 out of 1,339 | 17th |
Industry group Drugs | 1,042 out of 1,242 | 16th |
Industry Pharmaceutical Preparations | 757 out of 896 | 16th |
Source: SEC filing on March 28, 2023.
Niffenegger's colleagues
We found two more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2022.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020